Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors
US10906915B2 · kind B2 · utility
3Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 12, 2016 |
| Grant date | Feb 2, 2021 |
| Priority date | — |
| Expiry date | Dec 12, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.